PRODH and breast carcinoma: NSAIDs, considered in cancer prevention due to their inhibitory effect on cyclooxygenases (COX), have recently been proposed to exert their antineoplastic activity through the activation of PPARγ, which induces proline dehydrogenase/proline oxidase (PRODH/POX)-dependent apoptosis in breast cancer cells [216].